EUVIMEDEUVIMED entdecken
Crossref

Low-Cost IoT System for Real-Time Monitoring of Oncology Drug Cold Chain in Resource-Limited Settings

Italo Lon-Kan, Carlos Lon-Kan

JCO Global Oncology · 01.11.2026 · 12 (Supplement_1) · 6-6

DOI: 10.1200/go-26-14000 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Global Oncology, erschienen am 01.11.2026. Verfasst von Italo Lon-Kan und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Monoclonal antibody therapies used in cancer treatment, including trastuzumab, bevacizumab, nivolumab, and pembrolizumab, require strict storage conditions between 2°C and 8°C to maintain stability and therapeutic efficacy. In many low- and middle-income countries (LMICs), cold chain monitoring still relies on manual temperature recording, which limits traceability and delays detection of temperature excursions. This study presents an adaptation of an open-source IoT-based system for real-time monitoring of oncology drug storage conditions. METHODS The proposed system is based on MHUTEMP, a low-cost IoT monitoring platform integrating an ESP32 microcontroller and a calibrated DS18B20 temperature sensor with ±0.1°C accuracy. The system uses WebSocket communication for real-time data transmission to a Node.js backend, enabling continuous monitoring with updates every 2 seconds. Data are visualized through a web-based dashboard and stored in a MongoDB database every 10 minutes for historical analysis and traceability. RESULTS The system enables continuous, real-time monitoring of storage conditions, eliminating reliance on manual recording. Its architecture allows immediate detection of temperature deviations that may compromise drug integrity. The platform demonstrates low latency (∼50 ms in local network conditions) and reliable performance, supporting both real-time visualization and historical data analysis. The open-source and cloud-independent design ensures full data ownership and scalability across multiple storage units. CONCLUSION This study demonstrates that low-cost IoT solutions can effectively support cold chain monitoring for oncology drugs in resource-limited settings. By ensuring temperature stability and enabling early detection of anomalies, the system contributes to preserving the efficacy of high-value cancer therapies and improving patient safety. This approach highlights the potential of locally developed technologies to address critical challenges in global cancer control.

Zitieren

APA

Lon-Kan, I., & Lon-Kan, C. (2026). Low-Cost IoT System for Real-Time Monitoring of Oncology Drug Cold Chain in Resource-Limited Settings. JCO Global Oncology, 12(Supplement_1), 6-6. https://doi.org/10.1200/go-26-14000

Vancouver

Lon-Kan I, Lon-Kan C. Low-Cost IoT System for Real-Time Monitoring of Oncology Drug Cold Chain in Resource-Limited Settings. JCO Global Oncology. 2026;12(Supplement_1):6-6. doi:10.1200/go-26-14000

BibTeX
@article{LonKan2026,
  author = {Lon-Kan, Italo and Lon-Kan, Carlos},
  title = {Low-Cost IoT System for Real-Time Monitoring of Oncology Drug Cold Chain in Resource-Limited Settings},
  journal = {JCO Global Oncology},
  year = {2026},
  volume = {12},
  number = {Supplement_1},
  pages = {6--6},
  doi = {10.1200/go-26-14000}
}
Kostenlos starten →